FDA Warning for Homeopathic Teething Tablets
According to the FDA, homeopathic teething tablets and gels are marketed by Hyland's, Baby Orajel Naturals and others. Such products have not been evaluated or approved by the agency for safety or efficacy, and the FDA has said it is also not aware of any proven health benefit associated with these remedies. However, the agency is not issuing a teething tablet recall at this time.
Parents and caregivers who do use these products should seek medical attention if their child experiences:
- Difficulty breathing
- Excessive sleepiness
- Muscle weakness
- Skin flushing
- Difficulty urinating
Following the FDA's September 30th alert, CVS announced that it was voluntarily withdrawing all homeopathic teething gels and tablets from its store shells. Products affected by the CVS action include:
- Baby Orajel Naturals Gel for Teething Pain, .33 oz
- Baby Orajel Naturals Gel for Teething Pain Nighttime Formula, .33 oz
- Baby Orajel Naturals Tablets for Teething Pain, 125 Count
- CVS Homeopathic Infant's Teething Tablet, 135 Count
- CVS Homeopathic Infants' Teething Liquid, .85 oz
- Hyland's Baby Nighttime Teething Tablets, 135 Count
- Hyland's Baby Teething Gel, .5 oz
- Hyland's Baby Teething Tablets, 13 Count
- Hyland's Baby Teething Tablets, 135 Count
- Hyland's Teething Gel, .33 oz
Hyland's has announced that it will no longer market its teething medications in the U.S., due to "confusion among parents and limited access to the medicines" created by the FDA's action.
In 2010, Hyland's did issue a voluntary recall for its teething tablets, after the products were linked to a number of adverse events typical of belladonna toxicity. The FDA determined that the pills contained inconsistent amounts of this ingredient, which can be poisonous if ingested in large amounts.
Compensation may be available to the families of children who were allegedly harmed by homeopathic teething pills and gels. To learn more about filing a teething tablet lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teething-tablet-lawsuit-evaluations-now-being-offered-by-bernstein-liebhard-llp-following-fda-warning-reports-of-injuries-and-deaths-300344703.html
SOURCE Bernstein Liebhard LLP